IsoPlexis, a venture-backed Yale-spinout company, is developing a diagnostic platform to accelerate immunology research and therapeutic development. In particular, we are developing critical solutions for the implementation of new therapeutic technologies. We are a multidisciplinary team of engineers, scientists, and software developers who thrive on scientific discovery and the development of life-changing therapeutic platforms.